Annual report pursuant to Section 13 and 15(d)

COMMITMENTS AND CONTINGENCIES (Detail Textuals)

v3.8.0.1
COMMITMENTS AND CONTINGENCIES (Detail Textuals) - License agreement - Analog Biosciences Inc
12 Months Ended
Aug. 31, 2017
Loss Contingencies [Line Items]  
Percentage of cash consideration 25.00%
Percentage of earned royalties 1.00%